X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3402) 3402
Book Review (436) 436
Publication (224) 224
Book Chapter (12) 12
Conference Proceeding (7) 7
Magazine Article (5) 5
Reference (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ranibizumab (2861) 2861
index medicus (2822) 2822
humans (2735) 2735
ophthalmology (2435) 2435
male (1835) 1835
female (1813) 1813
intravitreal injections (1679) 1679
aged (1559) 1559
macular degeneration (1537) 1537
bevacizumab (1534) 1534
angiogenesis inhibitors - administration & dosage (1339) 1339
vascular endothelial growth factor a - antagonists & inhibitors (1294) 1294
middle aged (1178) 1178
treatment outcome (1056) 1056
aged, 80 and over (960) 960
vascular endothelial growth factor (940) 940
tomography, optical coherence (930) 930
retrospective studies (819) 819
visual acuity (803) 803
follow-up studies (770) 770
angiogenesis inhibitors - therapeutic use (762) 762
fluorescein angiography (751) 751
endothelial growth-factor (715) 715
macular degeneration - drug therapy (696) 696
visual acuity - physiology (609) 609
choroidal neovascularization - drug therapy (591) 591
antibodies, monoclonal, humanized (590) 590
eye diseases (580) 580
antibodies, monoclonal, humanized - administration & dosage (564) 564
ranibizumab - administration & dosage (524) 524
genetic structures (517) 517
diabetic retinopathy (515) 515
wet macular degeneration - drug therapy (513) 513
prospective studies (505) 505
age-related macular degeneration (504) 504
macular edema - drug therapy (499) 499
choroidal neovascularization (485) 485
photodynamic therapy (448) 448
antibodies, monoclonal - administration & dosage (437) 437
care and treatment (435) 435
retina (411) 411
therapy (403) 403
aflibercept (388) 388
verteporfin (370) 370
adult (364) 364
physiological aspects (363) 363
neovascularization (360) 360
antibodies, monoclonal, humanized - therapeutic use (359) 359
edema (350) 350
injection (346) 346
degeneration (341) 341
diabetic retinopathy - drug therapy (341) 341
time factors (338) 338
optical coherence tomography (335) 335
age (327) 327
injections (327) 327
angiogenesis inhibitors - adverse effects (323) 323
sense organs (321) 321
diabetes (320) 320
analysis (307) 307
drug therapy (299) 299
visual acuity - drug effects (299) 299
patients (294) 294
abridged index medicus (285) 285
fundus oculi (285) 285
recombinant fusion proteins - administration & dosage (285) 285
medicine & public health (280) 280
research (275) 275
animals (271) 271
vitreous body (270) 270
retinopathy (265) 265
receptors, vascular endothelial growth factor - administration & dosage (264) 264
vegf (262) 262
intravitreal injection (251) 251
macular edema - etiology (251) 251
choroidal neovascularization - etiology (250) 250
studies (250) 250
diabetic macular edema (245) 245
anti-vegf (244) 244
eye (244) 244
pharmacology & pharmacy (244) 244
wet macular degeneration - diagnosis (240) 240
safety (238) 238
dose-response relationship, drug (232) 232
intravitreal bevacizumab (228) 228
antibodies, monoclonal - therapeutic use (225) 225
clinical trials (225) 225
ranibizumab - therapeutic use (222) 222
retina - pathology (222) 222
bevacizumab - administration & dosage (218) 218
choroidal neovascularization - diagnosis (218) 218
wet macular degeneration - physiopathology (215) 215
efficacy (213) 213
avastin (210) 210
macular degeneration - complications (210) 210
endothelial growth factors (209) 209
macular edema (209) 209
medical imaging (206) 206
angiogenesis (205) 205
risk factors (205) 205
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3174) 3174
German (96) 96
French (49) 49
Spanish (34) 34
Russian (16) 16
Polish (9) 9
Czech (8) 8
Japanese (5) 5
Korean (4) 4
Chinese (3) 3
Portuguese (3) 3
Swedish (3) 3
Danish (2) 2
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Icelandic (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 06/2010, Volume 51, Issue 6, pp. 3162 - 3170
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1193 - 1203
Journal Article
Current Eye Research, ISSN 0271-3683, 2/2013, Volume 38, Issue 2, pp. 278 - 282
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e67495 - e67495
The long term in vivo biocompatibility is an essential feature for the design and development of sustained drug release carriers. In the recent intraocular... 
VITRO | DIBLOCK COPOLYMER | BEHAVIOR | MULTIDISCIPLINARY SCIENCES | MACULAR DEGENERATION | RELEASE | NEOVASCULARIZATION | TRIBLOCK | CYTOTOXICITY | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Polyamines - administration & dosage | Retina - drug effects | Laminin - toxicity | Proteoglycans - toxicity | Biocompatible Materials - chemistry | Drug Carriers - administration & dosage | Laminin - administration & dosage | Collagen - chemistry | Drug Carriers - toxicity | Polyamines - toxicity | Proteoglycans - chemistry | Biocompatible Materials - toxicity | Drug Carriers - chemistry | Hydrogels - administration & dosage | Polyesters - administration & dosage | Collagen - toxicity | Female | Hydrogels - toxicity | Poloxamer - administration & dosage | Poloxamer - chemistry | Rabbits | Polyamines - chemistry | Proteoglycans - administration & dosage | Polyesters - toxicity | Collagen - administration & dosage | Poloxamer - toxicity | Polyesters - chemistry | Animals | Laminin - chemistry | Biocompatible Materials - administration & dosage | Retina - pathology | Drug Combinations | Hydrogels - chemistry | Drugs | Drug delivery systems | Biological products | Vehicles | Cell culture | Diabetic retinopathy | Media (culture) | Hydrogels | Laboratories | Toxicity | Chemical engineering | Electrophysiology | Thermosensitive | Cytotoxicity | Drug delivery | Drug development | Phase transitions | Block copolymers | Macular degeneration | Pluronic F127 | Biomedical materials | Extracellular matrix | Biocompatibility | Vascular endothelial growth factor | Controlled release | Biodegradation | Phase transformations | Tissue engineering | Therapeutic applications | Gelation | Histology | Photography | Medicine | Carriers | Stem cells | Sustained release | In vivo methods and tests | Index Medicus
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 04/2013, Volume 131, Issue 4, pp. 456 - 461
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article